nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—rheumatoid arthritis	0.876	1	CbGaD
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—CTSD—rheumatoid arthritis	0.00489	0.0461	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PIP4K2C—rheumatoid arthritis	0.00429	0.0405	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PRTN3—rheumatoid arthritis	0.00426	0.0402	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—rheumatoid arthritis	0.00326	0.0307	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—KIF5A—rheumatoid arthritis	0.00305	0.0288	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—DPP4—rheumatoid arthritis	0.00222	0.0209	CbGpPWpGaD
Icatibant—ANPEP—parotid gland—rheumatoid arthritis	0.0021	0.176	CbGeAlD
Icatibant—BDKRB2—tendon—rheumatoid arthritis	0.00204	0.17	CbGeAlD
Icatibant—ANPEP—saliva-secreting gland—rheumatoid arthritis	0.00201	0.168	CbGeAlD
Icatibant—ANPEP—connective tissue—rheumatoid arthritis	0.00185	0.155	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—NOS3—rheumatoid arthritis	0.00177	0.0167	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CX3CR1—rheumatoid arthritis	0.00172	0.0162	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL6—rheumatoid arthritis	0.00154	0.0145	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—PRDM1—rheumatoid arthritis	0.00153	0.0144	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR6—rheumatoid arthritis	0.0015	0.0142	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL21—rheumatoid arthritis	0.00147	0.0138	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—ETS1—rheumatoid arthritis	0.00141	0.0133	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—MPO—rheumatoid arthritis	0.0014	0.0132	CbGpPWpGaD
Icatibant—ANPEP—lymphoid tissue—rheumatoid arthritis	0.00135	0.113	CbGeAlD
Icatibant—ANPEP—digestive system—rheumatoid arthritis	0.00134	0.112	CbGeAlD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—VDR—rheumatoid arthritis	0.00131	0.0123	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL6—rheumatoid arthritis	0.0013	0.0122	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—CTSD—rheumatoid arthritis	0.00129	0.0121	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—IL1A—rheumatoid arthritis	0.00128	0.0121	CbGpPWpGaD
Icatibant—ANPEP—tendon—rheumatoid arthritis	0.00127	0.106	CbGeAlD
Icatibant—BDKRB2—Direct p53 effectors—TNFRSF10A—rheumatoid arthritis	0.00126	0.0119	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—GATA3—rheumatoid arthritis	0.00126	0.0119	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCL21—rheumatoid arthritis	0.00124	0.0117	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CDK6—rheumatoid arthritis	0.00119	0.0113	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—rheumatoid arthritis	0.00117	0.011	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.00103	0.00972	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.000983	0.00928	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—IRF5—rheumatoid arthritis	0.000943	0.00889	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.000906	0.00854	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.000807	0.00761	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR5—rheumatoid arthritis	0.0008	0.00754	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—CTSD—rheumatoid arthritis	0.000789	0.00744	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.000785	0.0074	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL13—rheumatoid arthritis	0.000764	0.00721	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.000751	0.00708	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL21—rheumatoid arthritis	0.000749	0.00706	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—LEP—rheumatoid arthritis	0.000712	0.00672	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.000706	0.00666	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—EDEM3—rheumatoid arthritis	0.000677	0.00639	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.000645	0.00609	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.000645	0.00609	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—SAA1—rheumatoid arthritis	0.000639	0.00603	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ST6GALNAC5—rheumatoid arthritis	0.000637	0.00601	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—C5—rheumatoid arthritis	0.000633	0.00597	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.000632	0.00596	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.000631	0.00595	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—POMC—rheumatoid arthritis	0.000612	0.00577	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.000608	0.00573	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR6—rheumatoid arthritis	0.000595	0.00561	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—SYVN1—rheumatoid arthritis	0.000576	0.00543	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—KIF5A—rheumatoid arthritis	0.000576	0.00543	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—SAA1—rheumatoid arthritis	0.000572	0.00539	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.000552	0.00521	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—ADRBK1—rheumatoid arthritis	0.00055	0.00518	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.000549	0.00518	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—VDR—rheumatoid arthritis	0.000546	0.00515	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL2—rheumatoid arthritis	0.000544	0.00514	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.000541	0.00511	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—SAA1—rheumatoid arthritis	0.000532	0.00502	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.000518	0.00489	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—PTK2—rheumatoid arthritis	0.000517	0.00488	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—rheumatoid arthritis	0.000515	0.00485	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.000507	0.00478	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.000503	0.00475	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CD4—rheumatoid arthritis	0.000496	0.00468	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—SPP1—rheumatoid arthritis	0.000494	0.00466	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—rheumatoid arthritis	0.000492	0.00465	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.000492	0.00464	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.000485	0.00457	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—SLC25A12—rheumatoid arthritis	0.000483	0.00455	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—FAS—rheumatoid arthritis	0.000476	0.00449	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.000473	0.00446	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.000464	0.00437	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL12—rheumatoid arthritis	0.000463	0.00437	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.000463	0.00436	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.000454	0.00428	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000444	0.00418	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.000433	0.00408	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.000433	0.00408	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.000423	0.00399	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000423	0.00399	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—DPP4—rheumatoid arthritis	0.000418	0.00395	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.000417	0.00394	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.000412	0.00389	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL10—rheumatoid arthritis	0.000409	0.00386	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.000403	0.0038	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.000401	0.00378	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—FN1—rheumatoid arthritis	0.000392	0.0037	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000384	0.00362	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—C5—rheumatoid arthritis	0.000383	0.00362	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.000376	0.00355	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.000368	0.00347	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.000368	0.00347	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR6—rheumatoid arthritis	0.00036	0.0034	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—B3GNT2—rheumatoid arthritis	0.000356	0.00336	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCL5—rheumatoid arthritis	0.000352	0.00332	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—MMP2—rheumatoid arthritis	0.000349	0.0033	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000336	0.00317	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.00033	0.00311	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL3—rheumatoid arthritis	0.00033	0.00311	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.000325	0.00307	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000322	0.00304	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—rheumatoid arthritis	0.000317	0.00299	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—HSPD1—rheumatoid arthritis	0.000311	0.00293	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—C3—rheumatoid arthritis	0.00031	0.00292	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000305	0.00288	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.000294	0.00278	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.000294	0.00277	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.000291	0.00275	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.000288	0.00271	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.00028	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.00028	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000261	0.00247	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.00026	0.00245	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.000252	0.00238	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—POMC—rheumatoid arthritis	0.000248	0.00234	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000248	0.00234	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.000247	0.00233	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CTSD—rheumatoid arthritis	0.000243	0.00229	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000238	0.00224	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000237	0.00224	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.000237	0.00223	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.000227	0.00214	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000227	0.00214	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL21—rheumatoid arthritis	0.000227	0.00214	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.000224	0.00212	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000218	0.00205	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C5—rheumatoid arthritis	0.000217	0.00204	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000213	0.00201	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000212	0.002	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000204	0.00192	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000204	0.00192	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000197	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C5—rheumatoid arthritis	0.000197	0.00186	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000193	0.00182	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000192	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	0.000192	0.00181	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—C3—rheumatoid arthritis	0.000188	0.00177	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000186	0.00176	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000185	0.00174	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000182	0.00172	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PDE2A—rheumatoid arthritis	0.00018	0.0017	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—TP53—rheumatoid arthritis	0.000178	0.00168	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PLB1—rheumatoid arthritis	0.000172	0.00162	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000169	0.0016	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000169	0.0016	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000165	0.00156	CbGpPWpGaD
Icatibant—Body temperature increased—Penicillamine—rheumatoid arthritis	0.000165	0.0278	CcSEcCtD
Icatibant—Nausea—Ergocalciferol—rheumatoid arthritis	0.000164	0.0277	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000159	0.0015	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000158	0.00149	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000157	0.00148	CbGpPWpGaD
Icatibant—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.000154	0.0259	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000153	0.00144	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—POMC—rheumatoid arthritis	0.00015	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000148	0.00139	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000147	0.00139	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000145	0.00136	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000144	0.00136	CbGpPWpGaD
Icatibant—Rash—Auranofin—rheumatoid arthritis	0.000142	0.024	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000142	0.00134	CbGpPWpGaD
Icatibant—Dermatitis—Auranofin—rheumatoid arthritis	0.000142	0.024	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCL13—rheumatoid arthritis	0.00014	0.00132	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.00014	0.00132	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP1—rheumatoid arthritis	0.000139	0.00131	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—LEP—rheumatoid arthritis	0.000134	0.00127	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000134	0.00127	CbGpPWpGaD
Icatibant—Nausea—Auranofin—rheumatoid arthritis	0.000134	0.0226	CcSEcCtD
Icatibant—Rash—Penicillamine—rheumatoid arthritis	0.000131	0.0222	CcSEcCtD
Icatibant—Dermatitis—Penicillamine—rheumatoid arthritis	0.000131	0.0221	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000131	0.00124	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.000127	0.0012	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000126	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TLE3—rheumatoid arthritis	0.000126	0.00119	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000125	0.00118	CbGpPWpGaD
Icatibant—Nausea—Penicillamine—rheumatoid arthritis	0.000124	0.0209	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000121	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RB—rheumatoid arthritis	0.00012	0.00114	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000119	0.00112	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C5—rheumatoid arthritis	0.000116	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000116	0.0011	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000116	0.00109	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.000116	0.00109	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—POMC—rheumatoid arthritis	0.000115	0.00109	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000114	0.00108	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—rheumatoid arthritis	0.000113	0.00107	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000109	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCR6—rheumatoid arthritis	0.000109	0.00103	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000109	0.00102	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000108	0.00102	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MMP2—rheumatoid arthritis	0.000107	0.00101	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000107	0.00101	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NCF2—rheumatoid arthritis	0.000106	0.001	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C3—rheumatoid arthritis	0.000106	0.001	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000104	0.000977	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000104	0.000977	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—GZMB—rheumatoid arthritis	0.000103	0.000971	CbGpPWpGaD
Icatibant—Anaphylactic shock—Leflunomide—rheumatoid arthritis	0.000102	0.0173	CcSEcCtD
Icatibant—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.0001	0.0169	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCL2—rheumatoid arthritis	9.99e-05	0.000943	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CCL3—rheumatoid arthritis	9.99e-05	0.000943	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—rheumatoid arthritis	9.86e-05	0.00093	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SAA1—rheumatoid arthritis	9.77e-05	0.000922	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2RA—rheumatoid arthritis	9.72e-05	0.000916	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C3—rheumatoid arthritis	9.63e-05	0.000909	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NCF1—rheumatoid arthritis	9.57e-05	0.000903	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CD28—rheumatoid arthritis	9.2e-05	0.000868	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CXCL8—rheumatoid arthritis	8.93e-05	0.000843	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.66e-05	0.000817	CbGpPWpGaD
Icatibant—Body temperature increased—Azathioprine—rheumatoid arthritis	8.57e-05	0.0145	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCL12—rheumatoid arthritis	8.5e-05	0.000802	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—POMC—rheumatoid arthritis	8.48e-05	0.0008	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6ST—rheumatoid arthritis	8.42e-05	0.000795	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.4e-05	0.000793	CbGpPWpGaD
Icatibant—Body temperature increased—Leflunomide—rheumatoid arthritis	8.1e-05	0.0137	CcSEcCtD
Icatibant—Hypersensitivity—Azathioprine—rheumatoid arthritis	7.99e-05	0.0135	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.92e-05	0.000748	CbGpPWpGaD
Icatibant—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	7.91e-05	0.0133	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SYK—rheumatoid arthritis	7.9e-05	0.000745	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.75e-05	0.000731	CbGpPWpGaD
Icatibant—Nervous system disorder—Cyclosporine—rheumatoid arthritis	7.75e-05	0.0131	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—POMC—rheumatoid arthritis	7.71e-05	0.000727	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—STAT1—rheumatoid arthritis	7.62e-05	0.000719	CbGpPWpGaD
Icatibant—Hypersensitivity—Leflunomide—rheumatoid arthritis	7.55e-05	0.0127	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—rheumatoid arthritis	7.54e-05	0.000711	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6R—rheumatoid arthritis	7.52e-05	0.000709	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL10—rheumatoid arthritis	7.51e-05	0.000708	CbGpPWpGaD
Icatibant—Anaphylactic shock—Prednisolone—rheumatoid arthritis	7.19e-05	0.0121	CcSEcCtD
Icatibant—Dizziness—Azathioprine—rheumatoid arthritis	7.17e-05	0.0121	CcSEcCtD
Icatibant—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	7.03e-05	0.0118	CcSEcCtD
Icatibant—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	6.89e-05	0.0116	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MMP3—rheumatoid arthritis	6.85e-05	0.000646	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—TYK2—rheumatoid arthritis	6.85e-05	0.000646	CbGpPWpGaD
Icatibant—Rash—Azathioprine—rheumatoid arthritis	6.84e-05	0.0115	CcSEcCtD
Icatibant—Dermatitis—Azathioprine—rheumatoid arthritis	6.83e-05	0.0115	CcSEcCtD
Icatibant—Headache—Azathioprine—rheumatoid arthritis	6.8e-05	0.0115	CcSEcCtD
Icatibant—Dizziness—Leflunomide—rheumatoid arthritis	6.77e-05	0.0114	CcSEcCtD
Icatibant—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	6.62e-05	0.0112	CcSEcCtD
Icatibant—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	6.6e-05	0.0111	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PTK2—rheumatoid arthritis	6.59e-05	0.000622	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.56e-05	0.000619	CbGpPWpGaD
Icatibant—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	6.47e-05	0.0109	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCL5—rheumatoid arthritis	6.46e-05	0.00061	CbGpPWpGaD
Icatibant—Rash—Leflunomide—rheumatoid arthritis	6.46e-05	0.0109	CcSEcCtD
Icatibant—Dermatitis—Leflunomide—rheumatoid arthritis	6.45e-05	0.0109	CcSEcCtD
Icatibant—Nausea—Azathioprine—rheumatoid arthritis	6.44e-05	0.0109	CcSEcCtD
Icatibant—Headache—Leflunomide—rheumatoid arthritis	6.42e-05	0.0108	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CSF2—rheumatoid arthritis	6.37e-05	0.000601	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2—rheumatoid arthritis	6.27e-05	0.000592	CbGpPWpGaD
Icatibant—Body temperature increased—Cyclosporine—rheumatoid arthritis	6.25e-05	0.0105	CcSEcCtD
Icatibant—Nausea—Leflunomide—rheumatoid arthritis	6.08e-05	0.0103	CcSEcCtD
Icatibant—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	6e-05	0.0101	CcSEcCtD
Icatibant—Anaphylactic shock—Betamethasone—rheumatoid arthritis	6e-05	0.0101	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—SPP1—rheumatoid arthritis	5.99e-05	0.000565	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.96e-05	0.000562	CbGpPWpGaD
Icatibant—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.89e-05	0.00993	CcSEcCtD
Icatibant—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.89e-05	0.00993	CcSEcCtD
Icatibant—Hypersensitivity—Cyclosporine—rheumatoid arthritis	5.82e-05	0.00982	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCR5—rheumatoid arthritis	5.82e-05	0.000549	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL2RA—rheumatoid arthritis	5.74e-05	0.000541	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL2—rheumatoid arthritis	5.7e-05	0.000537	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C3—rheumatoid arthritis	5.69e-05	0.000537	CbGpPWpGaD
Icatibant—Body temperature increased—Hydrocortisone—rheumatoid arthritis	5.55e-05	0.00937	CcSEcCtD
Icatibant—Hypersensitivity—Prednisolone—rheumatoid arthritis	5.3e-05	0.00894	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—LEP—rheumatoid arthritis	5.3e-05	0.0005	CbGpPWpGaD
Icatibant—Body temperature increased—Triamcinolone—rheumatoid arthritis	5.23e-05	0.00882	CcSEcCtD
Icatibant—Dizziness—Cyclosporine—rheumatoid arthritis	5.23e-05	0.00882	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisone—rheumatoid arthritis	5.23e-05	0.00882	CcSEcCtD
Icatibant—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	5.18e-05	0.00873	CcSEcCtD
Icatibant—Nervous system disorder—Prednisone—rheumatoid arthritis	5.13e-05	0.00865	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—FN1—rheumatoid arthritis	5e-05	0.000471	CbGpPWpGaD
Icatibant—Rash—Cyclosporine—rheumatoid arthritis	4.98e-05	0.00841	CcSEcCtD
Icatibant—Dermatitis—Cyclosporine—rheumatoid arthritis	4.98e-05	0.0084	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL6ST—rheumatoid arthritis	4.98e-05	0.000469	CbGpPWpGaD
Icatibant—Headache—Cyclosporine—rheumatoid arthritis	4.95e-05	0.00835	CcSEcCtD
Icatibant—Hypersensitivity—Triamcinolone—rheumatoid arthritis	4.87e-05	0.00822	CcSEcCtD
Icatibant—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	4.86e-05	0.0082	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CD80—rheumatoid arthritis	4.79e-05	0.000452	CbGpPWpGaD
Icatibant—Dizziness—Prednisolone—rheumatoid arthritis	4.76e-05	0.00802	CcSEcCtD
Icatibant—Body temperature increased—Betamethasone—rheumatoid arthritis	4.75e-05	0.008	CcSEcCtD
Icatibant—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.75e-05	0.008	CcSEcCtD
Icatibant—Nausea—Cyclosporine—rheumatoid arthritis	4.7e-05	0.00792	CcSEcCtD
Icatibant—Dizziness—Hydrocortisone—rheumatoid arthritis	4.65e-05	0.00784	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—POMC—rheumatoid arthritis	4.55e-05	0.000429	CbGpPWpGaD
Icatibant—Rash—Prednisolone—rheumatoid arthritis	4.54e-05	0.00765	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—rheumatoid arthritis	4.53e-05	0.00764	CcSEcCtD
Icatibant—Headache—Prednisolone—rheumatoid arthritis	4.51e-05	0.0076	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCL2—rheumatoid arthritis	4.45e-05	0.00042	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6R—rheumatoid arthritis	4.44e-05	0.000419	CbGpPWpGaD
Icatibant—Rash—Hydrocortisone—rheumatoid arthritis	4.43e-05	0.00747	CcSEcCtD
Icatibant—Dermatitis—Hydrocortisone—rheumatoid arthritis	4.43e-05	0.00746	CcSEcCtD
Icatibant—Headache—Hydrocortisone—rheumatoid arthritis	4.4e-05	0.00742	CcSEcCtD
Icatibant—Dizziness—Triamcinolone—rheumatoid arthritis	4.37e-05	0.00738	CcSEcCtD
Icatibant—Anaphylactic shock—Methotrexate—rheumatoid arthritis	4.37e-05	0.00737	CcSEcCtD
Icatibant—Dizziness—Methylprednisolone—rheumatoid arthritis	4.37e-05	0.00736	CcSEcCtD
Icatibant—Nervous system disorder—Methotrexate—rheumatoid arthritis	4.28e-05	0.00723	CcSEcCtD
Icatibant—Nausea—Prednisolone—rheumatoid arthritis	4.27e-05	0.00721	CcSEcCtD
Icatibant—Nausea—Hydrocortisone—rheumatoid arthritis	4.17e-05	0.00704	CcSEcCtD
Icatibant—Rash—Triamcinolone—rheumatoid arthritis	4.17e-05	0.00703	CcSEcCtD
Icatibant—Dermatitis—Triamcinolone—rheumatoid arthritis	4.17e-05	0.00703	CcSEcCtD
Icatibant—Rash—Methylprednisolone—rheumatoid arthritis	4.16e-05	0.00702	CcSEcCtD
Icatibant—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.16e-05	0.00701	CcSEcCtD
Icatibant—Headache—Triamcinolone—rheumatoid arthritis	4.14e-05	0.00699	CcSEcCtD
Icatibant—Headache—Methylprednisolone—rheumatoid arthritis	4.14e-05	0.00697	CcSEcCtD
Icatibant—Body temperature increased—Prednisone—rheumatoid arthritis	4.13e-05	0.00697	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TYK2—rheumatoid arthritis	4.04e-05	0.000381	CbGpPWpGaD
Icatibant—Dizziness—Betamethasone—rheumatoid arthritis	3.97e-05	0.00669	CcSEcCtD
Icatibant—Dizziness—Dexamethasone—rheumatoid arthritis	3.97e-05	0.00669	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—NOS3—rheumatoid arthritis	3.97e-05	0.000374	CbGpPWpGaD
Icatibant—Nausea—Triamcinolone—rheumatoid arthritis	3.93e-05	0.00663	CcSEcCtD
Icatibant—Nausea—Methylprednisolone—rheumatoid arthritis	3.92e-05	0.00661	CcSEcCtD
Icatibant—Hypersensitivity—Prednisone—rheumatoid arthritis	3.85e-05	0.0065	CcSEcCtD
Icatibant—Rash—Dexamethasone—rheumatoid arthritis	3.78e-05	0.00638	CcSEcCtD
Icatibant—Rash—Betamethasone—rheumatoid arthritis	3.78e-05	0.00638	CcSEcCtD
Icatibant—Dermatitis—Betamethasone—rheumatoid arthritis	3.78e-05	0.00638	CcSEcCtD
Icatibant—Dermatitis—Dexamethasone—rheumatoid arthritis	3.78e-05	0.00638	CcSEcCtD
Icatibant—Headache—Dexamethasone—rheumatoid arthritis	3.76e-05	0.00634	CcSEcCtD
Icatibant—Headache—Betamethasone—rheumatoid arthritis	3.76e-05	0.00634	CcSEcCtD
Icatibant—Nausea—Dexamethasone—rheumatoid arthritis	3.57e-05	0.00601	CcSEcCtD
Icatibant—Nausea—Betamethasone—rheumatoid arthritis	3.57e-05	0.00601	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CXCL8—rheumatoid arthritis	3.52e-05	0.000332	CbGpPWpGaD
Icatibant—Dizziness—Prednisone—rheumatoid arthritis	3.46e-05	0.00583	CcSEcCtD
Icatibant—Body temperature increased—Methotrexate—rheumatoid arthritis	3.45e-05	0.00582	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL2—rheumatoid arthritis	3.36e-05	0.000317	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—rheumatoid arthritis	3.35e-05	0.000316	CbGpPWpGaD
Icatibant—Rash—Prednisone—rheumatoid arthritis	3.3e-05	0.00556	CcSEcCtD
Icatibant—Dermatitis—Prednisone—rheumatoid arthritis	3.29e-05	0.00555	CcSEcCtD
Icatibant—Headache—Prednisone—rheumatoid arthritis	3.27e-05	0.00552	CcSEcCtD
Icatibant—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.22e-05	0.00543	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MMP9—rheumatoid arthritis	3.18e-05	0.0003	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NFKB1—rheumatoid arthritis	3.15e-05	0.000297	CbGpPWpGaD
Icatibant—Nausea—Prednisone—rheumatoid arthritis	3.11e-05	0.00524	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.1e-05	0.000292	CbGpPWpGaD
Icatibant—Dizziness—Methotrexate—rheumatoid arthritis	2.89e-05	0.00487	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.86e-05	0.00027	CbGpPWpGaD
Icatibant—Rash—Methotrexate—rheumatoid arthritis	2.75e-05	0.00465	CcSEcCtD
Icatibant—Dermatitis—Methotrexate—rheumatoid arthritis	2.75e-05	0.00464	CcSEcCtD
Icatibant—Headache—Methotrexate—rheumatoid arthritis	2.74e-05	0.00462	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.62e-05	0.000248	CbGpPWpGaD
Icatibant—Nausea—Methotrexate—rheumatoid arthritis	2.6e-05	0.00438	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TP53—rheumatoid arthritis	2.16e-05	0.000204	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—IL6—rheumatoid arthritis	1.98e-05	0.000187	CbGpPWpGaD
